Timber Creek Capital Management LLC Decreases Stock Position in Danaher Co. (NYSE:DHR)

Timber Creek Capital Management LLC reduced its holdings in Danaher Co. (NYSE:DHR - Free Report) by 8.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,241 shares of the conglomerate's stock after selling 1,326 shares during the period. Timber Creek Capital Management LLC's holdings in Danaher were worth $3,499,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Vawter Financial Ltd. purchased a new position in shares of Danaher during the 4th quarter valued at approximately $234,000. Schubert & Co boosted its holdings in Danaher by 1,532.8% in the 4th quarter. Schubert & Co now owns 39,530 shares of the conglomerate's stock worth $9,074,000 after buying an additional 37,109 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund increased its stake in Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after buying an additional 2,202 shares in the last quarter. Kestra Investment Management LLC acquired a new position in shares of Danaher during the fourth quarter valued at approximately $88,000. Finally, Venturi Wealth Management LLC boosted its stake in shares of Danaher by 13.5% in the fourth quarter. Venturi Wealth Management LLC now owns 4,975 shares of the conglomerate's stock worth $1,142,000 after acquiring an additional 592 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Trading Up 0.9 %

Shares of NYSE:DHR traded up $1.91 during mid-day trading on Friday, reaching $209.86. 6,209,935 shares of the company were exchanged, compared to its average volume of 4,574,762. The firm's 50-day simple moving average is $227.21 and its 200 day simple moving average is $247.52. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a market cap of $151.58 billion, a price-to-earnings ratio of 39.75, a P/E/G ratio of 2.61 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm earned $2.09 EPS. Equities research analysts forecast that Danaher Co. will post 7.67 EPS for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.61%. Danaher's dividend payout ratio is 20.45%.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 11.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on DHR. Wells Fargo & Company reduced their price objective on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Royal Bank of Canada reissued an "outperform" rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Barclays dropped their price objective on shares of Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Robert W. Baird decreased their target price on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Finally, Scotiabank started coverage on Danaher in a report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 target price on the stock. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.